Valuation: Procter & Gamble Health Limited

Market Cap 89.87B 938M 823M 777M 708M 1.33B 1.34B 9.3B 3.6B 45.91B 3.52B 3.44B 148B P/E 2027 *
24.5x
P/E 2028 * 22x
Enterprise Value 89.87B 938M 823M 777M 708M 1.33B 1.34B 9.3B 3.6B 45.91B 3.52B 3.44B 148B EV / Sales 2027 *
5.81x
EV / Sales 2028 * 5.15x
Free-Float
47.81%
Yield 2027 *
2.01%
Yield 2028 * 2.18%
1 day-0.17%
1 week-1.60%
Current month-6.01%
1 month-7.12%
3 months-13.24%
6 months+9.61%
Current year-5.03%
1 week 5,401
Extreme 5401
5,549.95
1 month 5,324.4
Extreme 5324.4
5,820
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 31/03/2018
Director of Finance/CFO - 30/09/2025
Chief Tech/Sci/R&D Officer - 31/08/2025
Director TitleAgeSince
Director/Board Member 57 31/03/2018
Director/Board Member 51 31/05/2019
Chairman 69 31/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-1.60%-15.03%+9.01% 938M
+0.12%+0.81%+13.81%+64.78% 46.37B
+1.09%+0.36%+39.50%+107.67% 37.26B
+2.00%+3.78%+18.12%+99.54% 12.53B
+0.05%+0.37%-7.29%+18.68% 11.8B
0.00%0.00%+18.72%+139.63% 8.97B
-1.34%-2.73%+27.67%+37.52% 7.09B
-2.07%-2.75%+17.20%+202.97% 7.01B
+1.43%+2.22%+43.10%-14.21% 7.29B
-2.45%-0.59%-51.49%+4.53% 4.99B
Average -0.13%-0.01%+10.43%+67.01% 14.42B
Weighted average by Cap. +0.32%+0.53%+19.28%+78.70%

Financials

2027 *2028 *
Net sales 15.47B 161M 142M 134M 122M 228M 230M 1.6B 620M 7.91B 606M 593M 25.41B 17.43B 182M 160M 151M 137M 257M 259M 1.8B 699M 8.91B 683M 668M 28.63B
Net income 3.67B 38.31M 33.61M 31.75M 28.93M 54.16M 54.55M 380M 147M 1.88B 144M 141M 6.03B 4.09B 42.64M 37.42M 35.34M 32.21M 60.29M 60.72M 423M 164M 2.09B 160M 157M 6.71B
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,276
Date Price Change Volume
25/09/26 ₹5,414.15 -0.17% 306
24/09/26 ₹5,423.60 -0.32% 167
23/09/26 ₹5,441.25 -0.36% 171
22/09/26 ₹5,460.75 -0.82% 291
21/09/26 ₹5,506.15 +0.08% 415
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock